Select Page
After COVID-19, what's next for EU medicines policies?
EPHA #A2MDialogues
Register here

9 March 2021

16:00-17:00 CET

online

Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

A one-on-one interview with Professor Guido Rasi, former Executive Director, European Medicines Agency (EMA).

Professor Rasi will talk about about his time at the helm of Europe’s top regulator; the power balance between pharma and governments; the impact of the pandemic on the pharmaceutical regulatory framework and the innovation landscape and trends in Europe and beyond.

 

 

 

#A2MDialogues

Professor Guido Rasi

Former Executive Director 

European Medicines Agency

Interviewed by

Yannis Natsis,

Policy Manager, Universal Access to Affordable Medicines

European Public Health Alliance

Catch up on EPHA’s other #A2MDialogues below

Getting it right: Recommendations for a European BARDA

8 December 2020

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

Pharma & COVID19: Winners, losers, prospects

19 November  2020

The EU's IP strategy: Enabler or barrier?

27 October 2020

Unleashing meaningful innovation through regulatory reform

19 October 2020

Follow on social media

#A2MDialogues

#A2Msolutions

Contact

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA
yannis@epha.org